Efficacy of Yukmijihwang-tang on symptoms of Alzheimer disease
Open Access
- 25 June 2021
- journal article
- review article
- Published by Wolters Kluwer Health in Medicine
- Vol. 100 (25) , e26363
Abstract
Background: Alzheimer disease (AD) is the most common cause of dementia, which may lead to severe memory loss and other cognitive disorders. Yukmijihwang-tang (YMJ), a type of Korean traditional herbal medicine, has been shown to be effective against neurodegenerative diseases. Although a meta-analysis on the efficacy of YMJ on AD exists, the study had some limitations, and there have been several newly published studies assessing the effect of YMJ. Therefore, the purpose of this study is to evaluate the efficacy and safety of YMJ as a treatment for AD through a meta-analysis. Methods: A systematic search of the following electronic databases will be conducted to identify eligible studies: MEDLINE (PubMed), Elsevier (EMBASE), The Cochrane Central Register of Controlled Trials (CENTRAL), Cumulative Index to Nursing and Allied Health Literature (CINAHL), Korean Medical Database (KMBASE), Oriental Medicine Advanced Searching Integrated System (OASIS), Korean Traditional Knowledge Portal, Citation Information by NII (CiNii), China National Knowledge Infrastructure (CNKI). All randomized controlled trials assessing the efficacy and safety of YMJ on the symptoms of AD will be included. Two independent reviewers will perform article retrieval, deduplication, data screening, data extraction, quality evaluation, and data analyses using RevMan version 5.4. The Cochrane risk of bias tool will be used to assess the quality of the trials. Results: This study will provide synthesis of the cognitive function measured with neuropsychological tests, behavioral and psychological symptoms of dementia (BPSD), and activities of daily living (ADL) measured using validated scales. The clinical effective rate and adverse events will also be analyzed to assess the efficacy and safety of YMJ for treating AD. Conclusion: This systematic review will provide evidence for the efficacy and safety of YMJ in AD. Ethics and dissemination: Ethical approval is not required because individual patient data will not be included in this study. The study findings will be disseminated through conference presentations.Keywords
Funding Information
- Korea Institute of Oriental Medicine (KSN2021240)
- Ministry of Health and Welfare (HB16C0044)
This publication has 14 references indexed in Scilit:
- The neuropathological diagnosis of Alzheimer’s diseaseMolecular Neurodegeneration, 2019
- Yuk-Mi-Jihwang-Tang, a Traditional Korean Multiple Herbal Formulae, Improves Hippocampal Memory on Scopolamine Injection‐Induced Amnesia Model of C57BL/6 MiceEvidence-Based Complementary and Alternative Medicine, 2018
- The Comparative Effects of Yugmijihwangtang in Donguibogam and Experiment Research Results -Focusing on the Korean Medicine and Traditional Chinese Medicine-Herbal Formula Science, 2017
- A randomized, double-blind, placebo-controlled trial of a traditional herbal formula, Yukmijihwang-tang in elderly subjects with xerostomiaJournal of Ethnopharmacology, 2016
- The Study on the Korean Traditional Medical Treatment and System of Collaborative Practice Between Korean Traditional Medicine and Western Medicine for Dementia: Based on Analysis of Questionnaire Survey in Professional GroupJournal of Oriental Neuropsychiatry, 2012
- Inhibitory effect of Yukmijihwang-tang, a traditional herbal formula against testosterone-induced benign prostatic hyperplasia in ratsBMC Complementary and Alternative Medicine, 2012
- Yukmijihwang-tang Inhibits Receptor Activator for Nuclear Factor-κB Ligand–Induced Osteoclast DifferentiationJournal of Medicinal Food, 2011
- Alterations in Membrane Transport Function and Cell Viability Induced by ATP Depletion in Primary Cultured Rabbit Renal Proximal Tubular CellsThe Korean Journal of Physiology & Pharmacology, 2009
- Novel Pharmacotherapies for Alzheimer's DiseaseJournal of the Korean Medical Association, 2009
- Yukmijihwang-Tang Derivatives Enhance Cognitive Processing in Normal Young Adults: A Double-Blinded, Placebo-Controlled TrialThe American Journal of Chinese Medicine, 2005